Covidien Expands Sonicision Cordless Ultrasonic Dissection Device Portfolio

(RTTNews) - Covidien plc (COV) announced the expansion of its Sonicision Cordless Ultrasonic Dissection Device portfolio, following U.S. Food and Drug Administration 510(k) clearance of three additional device lengths: 13 cm, 26 cm, and 48 cm.

Covidien said it now offers surgeons more options when performing pediatric, urological and bariatric procedures on patients of all sizes.

The company noted that the Sonicision system gives surgeons complete freedom of movement in the operating room. Increased mobility eliminates the frustration of managing cords in a sterile field and helps to increase procedural efficiencies. In addition, reducing the number of cords in the operating room (OR) contributes to a safer OR and patient experience.

The Sonicision system is used in a wide variety of general, bariatric, colorectal, gynecological and urological surgical procedures. The device's streamlined design allows a surgeon's eyes to remain in the surgical field rather than on the instrument. The new device lengths allow surgeons to expand their use of the Sonicision system to an increasing number of procedures, including pediatric colectomy, splenectomy, and appendectomy.

The full cordless ultrasonic portfolio is currently available in the United States.